Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-HPV18 E7/Protein E7 Polyclonal Antibody

Catalog #:   PVV08902 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P06788
Overview

Catalog No.

PVV08902

Species reactivity

Human papillomavirus type 18

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant HPV18 E7/Protein E7 (Met1-Gln105).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:200, WB: 1:1000-1:4000

Target

E7, Protein E7

Concentration

1.22 mg/ml

Purification

Antigen affinity purification.

Accession

P06788

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
References

Development of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides., PMID:40476553

Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers., PMID:38978164

Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells., PMID:38967656

T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector., PMID:38858404

Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status., PMID:38577820

Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion., PMID:38415538

Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers., PMID:37104874

Human papillomavirus is an important risk factor for esophageal carcinoma in a Chinese population., PMID:36394699

Usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysis., PMID:35641882

HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women., PMID:35351184

A novel recombinant protein vaccine containing the different E7 proteins of the HPV16, 18, 6, 11 E7 linked to the HIV-1 Tat (47-57) improve cytotoxic immune responses., PMID:34313864

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody., PMID:33468698

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial., PMID:33271094

Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank., PMID:33248371

Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)., PMID:32816895

Tip60 and p300 function antagonistically in the epigenetic regulation of HPV18 E6/E7 genes in cervical cancer HeLa cells., PMID:32399935

Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18., PMID:32214362

Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma., PMID:32170783

A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer., PMID:32151670

Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population., PMID:31860383

Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies., PMID:30894687

A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer., PMID:30770966

Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women., PMID:30755156

Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer., PMID:30353680

Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer., PMID:30242022

Prediction and identification of human leukocyte antigen-A2-restricted cytotoxic T lymphocyte epitope peptides from the human papillomavirus 58 E7 protein., PMID:30008894

Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer., PMID:29938318

Serum Immune Profiling for Early Detection of Cervical Disease., PMID:29109779

Generation of affibody molecules specific for HPV16 E7 recognition., PMID:27659535

Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care., PMID:27175798

A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected]., PMID:26242403

Development of chimeric candidate vaccine against HPV18: a proof of concept., PMID:25929429

Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer., PMID:24729277

Peroxiredoxin 3 is a novel marker for cell proliferation in cervical cancer., PMID:24648924

High-risk HPV types and head and neck cancer., PMID:24615247

Anti-HPV-E7 seropositivity and risk of esophageal squamous cell carcinoma in a high-risk population in China., PMID:24356570

Detection of Immunoglobulin G against E7 of Human Papillomavirus in Non-Small-Cell Lung Cancer., PMID:23533408

Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study., PMID:23503618

Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18., PMID:23233027

High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner., PMID:23175360

Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo., PMID:23128977

Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody., PMID:22935825

InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers., PMID:22228147

Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study., PMID:22135254

Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection., PMID:21811748

Combining T-cell vaccination and application of agonistic anti-GITR mAb (DTA-1) induces complete eradication of HPV oncogene expressing tumors in mice., PMID:20145549

Estrogen contributes to non-pRb targeted HPV18 E7-caused cell proliferation and transformation., PMID:20009582

Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients., PMID:19210223

Antibody response for L1, E6, E7 HPV 16, and HPV 18 antigens in Tunisian women with cervical cancer., PMID:19117204

Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity., PMID:19095032

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-HPV18 E7/Protein E7 Polyclonal Antibody [PVV08902]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only